Jane Street Group, LLC Evolus, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$5.37 - $8.38 $8,055 - $12,570	-1,500 Reduced 6.82%	20,500 $133,000
Q3 2021 Nov 16, 2021	SELL	$7.36 - $13.67 $41,216 - $76,552	-5,600 Reduced 20.29%	22,000 $168,000
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $50,520 - $83,760	6,000 Added 27.78%	27,600 $349,000
Q1 2021 May 18, 2021	BUY	$3.2 - $16.51 $17,600 - $90,805	5,500 Added 34.16%	21,600 $281,000
Q4 2020 Feb 17, 2021	SELL	$2.92 - $4.84 $4,672 - $7,744	-1,600 Reduced 9.04%	16,100 $54,000
Q2 2020 Aug 17, 2020	SELL	$3.53 - $6.17 $17,297 - $30,233	-4,900 Reduced 21.68%	17,700 $94,000
Q2 2019 Aug 15, 2019	BUY	$13.19 - $28.36 $298,094 - $640,936	22,600 New	22,600 $330,000

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $708M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.